At a glance
- Excessive gingival display, colloquially referred to as a gummy smile, occurs when an atypical proportion of the maxillary gum tissue remains visible during dynamic facial expression.
- Excessive gingival display is rarely uniform in origin; it arises from muscular, skeletal, dentoalveolar, or soft tissue discrepancies, frequently occurring in combination.
- A comprehensive diagnostic evaluation begins with a static and dynamic extraoral and intraoral examination.
- Clinical classification of hyperactive gingival display is often categorized according to the specific perioral zones affected.
- Management of excessive gingival display depends entirely on the identified aetiological factors.
Understanding Hyperactive Upper Lip and Perioral Anatomy
Excessive gingival display, colloquially referred to as a gummy smile, occurs when an atypical proportion of the maxillary gum tissue remains visible during dynamic facial expression. A primary physiological driver of this condition is hyperkinesis, or muscular hyperactivity, of the elevator muscle complex of the upper lip. This anatomical network is predominantly composed of the levator labii superioris alaeque nasi (LLSAN), the levator labii superioris (LLS), and the zygomaticus minor. Under normal conditions, these paired muscle groups coordinate to elevate the lip by approximately six to eight millimetres from resting position to a full, uninhibited smile. When these muscles exert excessive contractile force, the upper lip retracts excessively upward, exposing substantial alveolar mucosa and marginal gingiva.
The levator labii superioris alaeque nasi is particularly influential because it inserts into both the lateral nasal cartilage and the upper lip dermis. Its excessive contraction pulls the central portion of the lip sharply superiorly while simultaneously flaring the nasal alae. Adjacent to it, the levator labii superioris elevates the intermediate zone of the lip, while the zygomaticus minor acts on the lateral corners. Neuromodulator therapy using botulinum toxin type A specifically targets these hyperdynamic muscle groups. By temporarily blocking the presynaptic exocytosis of acetylcholine at the neuromuscular junction, the neurotoxin dampens muscle contractility, thereby reducing lip elevation upon smiling while preserving resting lip posture.
Aetiology and Diagnostic Classification of Gingival Display
Excessive gingival display is rarely uniform in origin; it arises from muscular, skeletal, dentoalveolar, or soft tissue discrepancies, frequently occurring in combination. True muscular hyperactivity is defined by a normal resting philtrum length—typically twenty to twenty-two millimetres in adult females and twenty-two to twenty-four millimetres in adult males—accompanied by an excessive dynamic translation of the upper lip exceeding eight to ten millimetres during animation. In contrast, patients with vertical maxillary excess (VME) possess an overdeveloped maxillary basal bone, which presents as visible gingiva even when the perioral muscles are completely at rest.
Dentoalveolar aetiologies include altered passive eruption (APE), wherein the gingival complex fails to recede apically to the cementoenamel junction during tooth development, resulting in short, square-looking clinical crowns. Another structural cause is bimaxillary or maxillary dentoalveolar protrusion, an anterior flare of the alveolar bone and teeth often observed across varied global demographics, including South Asian populations. Accurate differential diagnosis is essential: botox for gummy smile specifically rectifies muscular hyperactivity and provides adjunctive benefit in mild skeletal discrepancies, but it cannot substitute for hard-tissue realignment or surgical periodontal excision when the primary defect is structural.
Clinical Presentation and Diagnostic Evaluation
A comprehensive diagnostic evaluation begins with a static and dynamic extraoral and intraoral examination. The clinician evaluates facial symmetry, vertical facial thirds, lip thickness, resting interlabial gap, and the dynamic smile line. An aesthetic smile generally reveals no more than two to three millimetres of marginal gingival tissue above the maxillary central incisors. Exposure exceeding three to four millimetres is clinically categorised as excessive gingival display. During clinical assessment, the practitioner prompts both social smiles and uninhibited peri-orbital (Duchenne) smiles to observe the maximal vector of muscular contraction.
Diagnostic imaging, such as low-dose cone-beam computed tomography (CBCT) or digital lateral cephalometric radiography, is employed whenever underlying skeletal dysmorphology is suspected. Digital photogrammetry and dynamic video analysis allow the practitioner to track the millimetric translation of the philtrum, vermilion border, and oral commissures from rest to peak contraction. Periodontal probing must also be performed to assess biological width, sulcus depth, and the position of the alveolar bone crest relative to the cementoenamel junction, ensuring that underlying periodontal pathology or delayed tooth eruption is not misattributed to perioral muscular hyperactivity.
Smile Line Topography and Muscle Mapping
Clinical classification of hyperactive gingival display is often categorized according to the specific perioral zones affected. An anterior gummy smile is driven predominantly by the levator labii superioris alaeque nasi and manifests as prominent gingival exposure between the maxillary canine teeth. A posterior gummy smile is characterised by normal anterior coverage but excessive gum exposure extending from the premolars to the first molars, driven primarily by the zygomaticus major and minor muscles. A mixed or complete display involves hypercontraction across both the anterior and posterior perioral muscular networks.
An asymmetric gummy smile occurs when unilateral hyperkinesis or structural skeletal tilting causes unequal tissue exposure between the right and left sides. Mapping these specific muscle vectors determines the exact anatomical placement of botulinum toxin. Injecting the anterior elevator apparatus corrects central display, whereas targeting more lateral musculature moderates posterior gingival exposure. This individualized mapping prevents over-treatment and ensures the patient retains natural, balanced smile dynamics across all perioral sectors.
Treatment Modalities and Evidence-Based Comparisons
Management of excessive gingival display depends entirely on the identified aetiological factors. Botulinum toxin type A injections represent the least invasive, fully reversible pharmacological option for muscular hyperactivity. Clinical studies demonstrate that targeted chemodenervation reduces gingival display by an average of three to five millimetres, offering high patient satisfaction with zero surgical downtime. However, the temporary nature of neurotoxin therapy necessitates retreatment every three to six months, which distinguishes it from definitive surgical interventions.
For patients seeking permanent results or those with multi-factorial aetiologies, alternatives include surgical lip repositioning, aesthetic crown lengthening (gingivectomy with or without osseous resection), and orthognathic surgery. Surgical lip repositioning restricts muscle pull by excising a strip of maxillary labial mucosa and suturing the lip in a more coronal position, though partial relapse can occur. Orthognathic surgery (specifically Le Fort I maxillary impaction) remains the gold standard for severe vertical maxillary excess exceeding seven to eight millimetres, whereas orthodontic intrusion using temporary anchorage devices (TADs) is preferred for isolated dentoalveolar extrusion.
The Clinical Injection Protocol Step by Step
Administration of botulinum toxin for a hyperactive upper lip is an outpatient procedure requiring precise anatomical landmarks. The patient is seated in a semi-reclined position, and the perioral skin is thoroughly disinfected with an antiseptic solution such as chlorhexidine or isopropyl alcohol. Topical anaesthetic cream or localized ice application may be used to minimise procedural discomfort, though the injections are typically well tolerated with minimal pain.
The standard anatomical target for anterior hyperkinesis is the Yonsei point. This landmark is located at the centre of a triangle formed by the levator labii superioris alaeque nasi, levator labii superioris, and zygomaticus minor, situated approximately one centimetre lateral to the nasal ala and one centimetre superior to the oral commissure line. Using a fine 30-gauge or 32-gauge micro-needle, the clinician administers one to two point five units of onabotulinumtoxinA (or equivalent neurotoxin) per side. The injection is placed superficially to mid-depth into the muscular fascia. The site is then compressed gently with dry gauze without rubbing to prevent uncontrolled dispersion into neighbouring structures.
Recovery, Post-Treatment Care, and Onset Timeline
The post-treatment recovery period is swift, permitting immediate resumption of non-strenuous daily activities. Patients are instructed to remain upright for at least four hours following injection to avoid migration of the neurotoxin. For the first twenty-four hours, patients should avoid vigorous cardiovascular exercise, saunas, facial massage, and excessive perioral manipulation. Minor localized erythema, mild swelling, or pinpoint ecchymosis (bruising) at the injection sites are standard physiological responses that resolve spontaneously within forty-eight hours.
The pharmacological onset of botulinum toxin is gradual. Initial muscle relaxation typically becomes perceptible within three to five days post-injection, with maximal clinical efficacy achieved between ten and fourteen days. During this peak period, the dynamic rise of the upper lip is visibly moderated, leaving the resting lip length unaltered. Patients are routinely scheduled for a two-week post-injection review to evaluate symmetry, measure the reduction in gingival display, and administer micro-dose adjustments if full balance has not yet been established.
Complications, Adverse Effects, and Management
While botulinum toxin therapy has an established safety profile, adverse events can occur if the neurotoxin diffuses into unintended adjacent musculature or if dosage is excessive. The most frequent minor complication is temporary asymmetry of the smile, which arises from uneven drug diffusion or pre-existing muscular imbalances. This is managed by placing a small supplementary dose in the hyperactive side at the two-week review. Overdosage can cause upper lip ptosis (excessive downward droop), an elongated dynamic philtrum, or a sensation of heaviness when speaking.
More severe functional complications include temporary oral incompetence, characterised by an inability to seal the lips tightly, resulting in minor speech alterations (difficulty articulating bilabial plosives such as 'p' and 'b'), transient drooling, or difficulty drinking through a straw. These functional impairments are self-limiting and resolve as the neuromuscular junction regenerates over six to twelve weeks. True systemic adverse effects or severe allergic responses are exceptionally rare when treatment is delivered by an experienced clinician adhering to standardized dosing protocols.
Long-Term Maintenance and Retreatment Strategies
Because the chemical denervation produced by botulinum toxin is entirely reversible through axonal sprouting and the synthesis of new motor endplates, maintaining the aesthetic result requires periodic retreatment. For most patients, therapeutic effects persist between three and six months. Retreatment is ideally scheduled as dynamic hypermobility begins to return but before the perioral muscles regain their baseline hypercontractile strength, maintaining continuous aesthetic control.
With repeated, regularly spaced injection cycles, some patients experience mild, beneficial muscle atrophy or learned behavioural changes in smile dynamics, allowing the interval between sessions to be extended. Clinicians must avoid excessively frequent dosing (intervals shorter than twelve weeks) or unnecessarily high doses to mitigate the theoretical risk of neutralizing antibody formation, which can cause secondary treatment failure. For patients desiring permanent changes after evaluating their aesthetic outcome with botulinum toxin, transitional surgical options such as surgical lip repositioning can be explored.
When to Seek Urgent Clinical Assessment
Patients undergoing neuromodulator therapy must be educated on the critical difference between normal post-injection transient sensations and genuine clinical red flags. Mild tenderness, localized tightness, or pinpoint bruising require only routine observation. Conversely, any sudden development of systemic symptoms—including difficulty swallowing (dysphagia), shortness of breath (dyspnoea), generalized muscular weakness, or systemic urticaria—warrants immediate emergency medical evaluation, as these may signal an unexpected hypersensitivity reaction or widespread systemic neurotoxin spread.
Urgent dental or maxillofacial review is also indicated if a patient experiences progressive, severe asymmetry interfering with normal mastication, persistent inability to close the mouth leading to corneal or oral dehydration, or signs of secondary soft-tissue infection at the injection site such as spreading erythema, increasing warmth, or purulent drainage. Prompt clinical examination ensures that corrective, supportive, or antimicrobial measures can be implemented before functional deficits impair daily activities.
Evidence and further reading
The clinical application of botulinum toxin type A for excessive gingival display is widely supported in peer-reviewed maxillofacial and aesthetic literature. Consensus statements published in the International Journal of Oral and Maxillofacial Surgery, the Aesthetic Surgery Journal, and the British Dental Journal consistently affirm that targeted injection of the levator labii superioris alaeque nasi complex provides a reliable, reversible, and minimally invasive treatment for dynamic gummy smile. Clinical research demonstrates predictable reductions in gingival exposure with high patient-reported satisfaction and negligible long-term morbidity when established anatomical landmarks, such as the Yonsei point, are utilized.
Professional dental and periodontal bodies, including the European Federation of Periodontology and the American Dental Association, emphasize the necessity of precise differential diagnosis prior to intervention. The consensus literature highlights that while botulinum toxin is an outstanding modality for pure hyperdynamic muscle action, it functions best as an adjunctive or diagnostic trial rather than a replacement for definitive surgical, orthodontic, or periodontic therapies when skeletal excess or altered passive eruption forms the primary aetiology.
Questions patients ask us
- How long do botox injections for a gummy smile last?
- The therapeutic effects of botulinum toxin for excessive gingival display typically last between three and six months. Individual longevity varies based on your metabolic rate, muscle mass, and the frequency of dynamic facial expressions. As the target perioral muscles regenerate new nerve endings, lip elevation gradually returns to baseline, at which point a maintenance treatment can be scheduled.
- Will botox for gummy smile make my face or smile look frozen?
- When administered by an experienced dental or maxillofacial clinician using conservative dosing, the treatment does not freeze your facial expressions. The injections specifically moderate the upward pull of the elevator muscles, allowing your smile to remain natural and balanced while keeping your resting lip posture, speech, and cheek animation completely unimpaired.
- Does getting botox in the upper lip hurt?
- Discomfort is minimal. The procedure uses ultra-fine micro-needles to deliver tiny quantities of neurotoxin directly beneath the skin. Most patients report a mild pinching sensation lasting only a few seconds. Topical numbing creams or localized ice application can be used prior to the injection to maximise comfort.
- Can botox fix all types of gummy smiles?
- No. Botulinum toxin is highly effective for gummy smiles caused by hyperactive upper lip elevator muscles. However, if your excessive gum exposure is due to altered passive eruption (short clinical crowns) or vertical maxillary excess (elongated jaw bone), treatments such as aesthetic crown lengthening, orthodontics, or orthognathic surgery are required for definitive correction.
- How quickly will I see results after the procedure?
- Initial relaxation of the upper lip muscles usually becomes noticeable within three to five days following the injections. The full clinical effect and final aesthetic result develop between ten and fourteen days post-treatment. A routine follow-up appointment is typically scheduled at two weeks to assess the outcome.
- What happens if the results are uneven or asymmetrical?
- Mild asymmetry can occasionally occur if the muscles on one side of your face are stronger or metabolise the neurotoxin differently. This is readily corrected at your two-week post-injection review by administering a micro-dose touch-up to the more active side to re-establish symmetrical lip elevation.
- Will the injections affect how I speak, eat, or drink?
- With standard, conservative dosing, normal eating, drinking, and speaking remain unaffected. If excessive doses are administered or the toxin diffuses, temporary difficulty with whistling, drinking through a straw, or pronouncing bilabial letters ('p', 'b', 'm') can occur. These symptoms are self-limiting and resolve as the toxin wears off.
- Is botox for a gummy smile permanent?
- No, botulinum toxin provides a temporary, completely reversible treatment. The body naturally metabolises the substance and restores neuromuscular transmission over three to six months. If you decide to discontinue treatment, your smile will return entirely to its original pre-treatment appearance without any structural damage.
When to see us
Get examined without waiting if any of the following applies to you:
- Sensitivity or pain that continues for more than a few days after cosmetic work
- A veneer, crown or bonded restoration that has chipped, debonded or feels high in the bite
- Gum inflammation or dark margins developing at the edge of a restoration
Get a written plan and cost before you commit
If this is what you are dealing with, the next step is a consultation with radiographs — cosmetic & smile design cases are seen by the specialist who handles that field. You get a written plan and staged cost before anything begins.
reception@dramitsharmahospital.comThis article is general education and does not replace an in-person examination, radiographs or a diagnosis by a qualified dentist.
Related in Cosmetic & Smile Design
Dental Crowns and Bridges: What They Are and When You Need One
How crowns and bridges restore damaged or missing teeth, the materials used, and what the process and aftercare involve.
Teeth Whitening and Tooth Stains: Causes and Treatment Options
Why teeth discolour over time, the difference between surface stains and deeper discolouration, and how professional whitening compares with home options.
Smile Makeover and Digital Smile Design
How veneers, bonding, whitening and gum contouring are combined into one planned cosmetic outcome.
Teeth Whitening: What Actually Works
In-office versus home whitening, realistic expectations, sensitivity management and what whitening cannot fix.
Black Triangles Between Teeth Causes and Treatment
Open gingival embrasures, commonly called black triangles between teeth and gums, occur when the interdental papilla recedes. Explore the anatomical causes, clinical classifications, restorative and orthodontic treatments, and long-term periodontal maintenance strategies.
Internal Tooth Bleaching for Discolored Nonvital Teeth
Internal tooth bleaching after root canal treatment is a conservative endodontic procedure that lightens intrinsically discoloured, non-vital teeth from within the pulp chamber, restoring natural aesthetics without requiring extensive structural removal for crowns or veneers.